Early stage minor salivary gland adenoid cystic carcinoma has favourable prognosis

Show full item record



Permalink

http://hdl.handle.net/10138/279331

Citation

Hämetoja , H , Hirvonen , K , Hagström , J , Leivo , I , Saarilahti , K , Apajalahti , S , Haglund , C , Mäkitie , A & Bäck , L 2017 , ' Early stage minor salivary gland adenoid cystic carcinoma has favourable prognosis ' , Virchows Archiv , vol. 471 , no. 6 , pp. 785-792 . https://doi.org/10.1007/s00428-017-2163-6

Title: Early stage minor salivary gland adenoid cystic carcinoma has favourable prognosis
Author: Hämetoja, Hanna; Hirvonen, Karoliina; Hagström, Jaana; Leivo, Ilmo; Saarilahti, Kauko; Apajalahti, Satu; Haglund, Caj; Mäkitie, Antti; Bäck, Leif
Contributor: University of Helsinki, Department of Pathology
University of Helsinki, HUS Head and Neck Center
University of Helsinki, HUS Head and Neck Center
University of Helsinki, Department of Oncology
University of Helsinki, Clinicum
University of Helsinki, Clinicum
University of Helsinki, HUS Head and Neck Center
University of Helsinki, HUS Head and Neck Center
Date: 2017-12
Language: eng
Number of pages: 8
Belongs to series: Virchows Archiv
ISSN: 0945-6317
URI: http://hdl.handle.net/10138/279331
Abstract: The purpose of the study was to evaluate the long-term outcome of minor salivary and mucous gland (MiSG) adenoid cystic carcinoma (ACC) of the head and neck and to compare the results with earlier reports including our recently published series on major salivary gland (MaSG) ACC. The study comprised 68 MiSG ACCs operated during 1974-2012 at the Helsinki University Hospital, Helsinki, Finland. Medical records and histological samples were reviewed. Our previously published cohort comprising 54 MaSG ACCs during the years from 1974 to 2009 was used for comparison. The most common locations were the oral cavity and sinonasal cavities. Most patients presented stages IV (33.8%) and I (23.5%) disease. Primary treatment with curative intent, mainly surgery, was offered for 64 patients. Thirty-three (51.6%) of these patients developed a disease recurrence and 22 (66.7%) patients in less than 5 years. The difference in the length of recurrence-free time (<5 vs. > 5 years) had an impact on OS and DSS (p <0.001) showing worse prognosis for the earlier recurring group. T classes 2-4 (p = 0.005, p <0.001, and p = 0.001, respectively) and stages II-IV (p = 0.019, p <0.001, and p = 0.002, respectively) were associated with worse OS, DSS, and DFS. MiSG ACC had a similar long-term survival compared to MaSG ACC. Patients with stage I MiSG ACC seem to carry a favourable prognosis compared with those with stages II, III, and IV tumours. It is thus noteworthy that stage II tumours represent a truly advanced disease entity warranting a more aggressive treatment approach.
Subject: Adenoid cystic carcinoma
Minor salivary gland
Malignancy
Oral cancer
Tumour
Prognosis
SURVIVAL
HEAD
NECK
3111 Biomedicine
3122 Cancers
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
10.1007_s00428_017_2163_6.pdf 556.5Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record